Cyanotech (OTCMKTS:CYAN) Posts Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) announced its quarterly earnings results on Monday. The biotechnology company reported $999.00 earnings per share for the quarter, Zacks reports. Cyanotech had a negative net margin of 7.14% and a negative return on equity of 21.74%.

Cyanotech Stock Performance

Shares of CYAN opened at $0.52 on Tuesday. The stock’s 50-day moving average is $0.44 and its two-hundred day moving average is $0.41. The stock has a market cap of $3.84 million, a PE ratio of -2.08 and a beta of 0.15. Cyanotech has a 12 month low of $0.21 and a 12 month high of $0.57. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.01 and a quick ratio of 0.29.

Cyanotech Company Profile

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.